Literature DB >> 3955237

Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line.

L A Fernandez, B Pope, C Lee, E Zayed.   

Abstract

There have been many reports of cases in which chronic increases in the numbers of natural killer (NK) cells have been reported. Whether this is reactive or neoplastic in nature has been debated. We report the first case of an aggressive NK cell leukemia in an adult with establishment of an NK cell line. A 70-year-old man had two spontaneous episodes of jejunal perforation and one month later developed a severe febrile illness with moderate splenomegaly. Hemoglobin was 13.1 g/L, and WBC count was 1.8 X 10(9)/L with 2% large granular lymphocytes (LGLs). Platelet count was 143 X 10(9)/L; prothrombin time (PT) and partial thromboplastin time (PTT) were normal. Bone marrow was infiltrated with 25% to 30% LGLs; serum lysozyme was normal. Serum LDH was initially 1,191 U/L and rose to 6,408 (normal 240 to 525 U/L). Ten days later, the WBC count increased to 99.9 X 10(9)/L with 70% LGL cells; the PT and PTT increased, and the platelet count dropped. No bacterial or viral cause of fever was identified. The cells from peripheral blood were LGLs that stained positively for acid phosphatase. All of the LGLs reacted with a monoclonal antibody reactive with NK cells (LEU-11b). Functionally, the patient's peripheral blood mononuclear cells (PBMs) demonstrated 100 times more lytic activity against K562 tumor cell lines than did normal PBMs. The patient's PBMs were propagated in vitro. The cultured cells showed the morphological, cytochemical, immunological, and functional characteristics of NK cells. In addition, partial trisomy involving chromosome 1 q with duplication in regions of q21 through q31 was observed in all metaphases analyzed. The extra chromosome 1q with duplication in regions q21 through q31 was translocated to the p-terminal of chromosome 5. One percent to 5% of normal PBMs comprise NK cells; in most cases, leukemias arise from normal phenotypic counterparts. This case demonstrated that aggressive NK cell leukemia may occur in adults. In addition, the chromosomal abnormalities suggest that this is not a reactive process but a malignancy.

Entities:  

Mesh:

Year:  1986        PMID: 3955237

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature.

Authors:  John Ryder; Xiaoqin Wang; Liming Bao; Sherilyn A Gross; Fu Hua; Richard D Irons
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

2.  Lymphocytosis of large granular lymphocytes associated with anemia and neutropenia: proof of monoclonality of the LGL-population, but benign clinical course.

Authors:  S Serke; A Neubauer; D Huhn
Journal:  Klin Wochenschr       Date:  1989-06-01

3.  EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.

Authors:  Alina Nicolae; Karthik A Ganapathi; Trinh Hoc-Tran Pham; Liqiang Xi; Carlos A Torres-Cabala; Nahid M Nanaji; Hongbin D Zha; Zhen Fan; Sybil Irwin; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

4.  Longstanding proliferation of CD3 negative large granular lymphocytes preceding the development of high grade non-Hodgkin's lymphoma.

Authors:  S R Smith; P G Middleton; P J Birch; L Morgan; P W Saunders
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

Review 5.  Natural killer cell lines in tumor immunotherapy.

Authors:  Min Cheng; Jian Zhang; Wen Jiang; Yongyan Chen; Zhigang Tian
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

6.  Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

Authors:  Ritsuro Suzuki; Makoto Murata; Masahiro Kami; Shigeki Ohtake; Norio Asou; Yoshihisa Kodera; Masao Tomonaga; Yasufumi Masaki; Shuya Kusumoto; Jin Takeuchi; Shin Matsuda; Hisamaru Hirai; m Seiichi Yorimitsu; Nobuyuki Hamajima; Masao Seto; Masanori Shimoyama; Ryuzo Ohno; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

Review 7.  Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.

Authors:  Christian Schmitt; Nouhoum Sako; Martine Bagot; Yenlin Huang; Philippe Gaulard; Armand Bensussan
Journal:  J Biomed Biotechnol       Date:  2011-04-20

8.  Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Authors:  Christopher P Fox; Claire Shannon-Lowe; Martin Rowe
Journal:  Herpesviridae       Date:  2011-09-07

9.  Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.

Authors:  Neil C Robson; Laura Hidalgo; Angeles Vicente; Alberto Varas; Tristan Mc Alpine; Heng Wei; Víctor G Martínez; Ana Entrena; Gustavo J Melen; Andrew S MacDonald; Alexander Phythian-Adams; Rosa Sacedón; Eugene Maraskovsky; Jonathan Cebon; Manuel Ramírez
Journal:  Cancer Res       Date:  2014-07-18       Impact factor: 12.701

10.  Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2.

Authors:  Sanja Perkovic; Sandra Basic-Kinda; Vladimir Gasparovic; Zeljko Krznaric; Jaksa Babel; Ivana Ilic; Igor Aurer; Drago Batinic
Journal:  Hematol Rep       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.